Gontivimab
Based on 1 Customer Validation
Gontivimab (ALX-0171; VR-465) is a poent anti-RSV prefusion F protein nanobody with a KD value of 0.113 nM. Gontivimab shows antiviral activity. Gontivimab reduces the RSV load in the nose and lung.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 95.11%
- CAS No.: 1257358-38-5
- Masse moléculaire:43.12 kDa
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Isotype
VH-VH-VH
Species Reactivity
Human
IC50 & Target
RSV-F
In Vitro
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Rats (RSV Tracy)[1]
-
Dosage:1-68 mg/kg
-
Administration:Intranasal administration or nebulization; once (day 2 or day 3) or twice (day 2 and day 3)
-
Result:Resulted in significant viral load reductions in the lungs ranging.
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Accession
A0A0X8XRK2
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
VH-VH-VH
Application
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 1257358-38-5
-
Appearance Liquid
-
Masse moléculaire 43.12 kDa
-
Color Colorless to light yellow
-
SMILES
[Gontivimab]
-
Synonyms
ALX-0171; VR-465
-
Livraison
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
Fiche technique (257 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)